Mallinckrodt (2013)   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: St Louis MO United States (2013)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Mallinckrodt (2013) (0) Acquired (1)

lubiprostone (amitiza) (16 trials)

Drugs in Phase 3 Trials (7)

Key: Mallinckrodt (2013) (0) Acquired (7)

glucose monohydrate (5 trials)

hydroxypropyl-beta-cyclodextrin (5 trials)

kremezin (7 trials)

tacrolimus (prograf) (1 trial)

tin-mesoporphyrin (5 trials)

ulimorelin (5 trials)

unoprostone isopropyl (rescula) (2 trials)

Drugs in Phase 2 Trials (7)

Key: Mallinckrodt (2013) (0) Acquired (7)

cellulose (2 trials)

cobiprostone (3 trials)

lactulose (cephulac) (1 trial)

ornithine (4 trials)

ru-101 (1 trial)

sodium chloride (1 trial)

tzp-102 (3 trials)

Drugs in Phase 1 Trials (1)

Key: Mallinckrodt (2013) (0) Acquired (1)

expressgraft-c9t1 skin tissue (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 53
  • # of Trial APIs: 16